Soranib contains Sorafenib 200 mg, a targeted therapy used for liver, kidney, and thyroid cancers. It works by blocking proteins that help cancer cells grow and spread.
| Generic Name | Sorafenib |
| Manufacturer | CIPLA |
| Packing | 120 Tablets |
| Prescribed For | Liver cancer, kidney cancer, and thyroid cancer |
| Expiry | December 2027 |
Sorafenat contains Sorafenib 200 mg, a targeted cancer therapy used for liver cancer, kidney cancer, and thyroid cancer. It works by blocking signals that promote tumor growth and spread.
| Generic Name | Sorafenib |
| Manufacturer | NATCO |
| Packing | 120 Tablets |
| Prescribed For | Liver cancer, kidney cancer, and thyroid cancer |
| Expiry | December 2027 |
Cabozer (Cabozantinib 40mg Tablet) is used to treat advanced kidney, liver, and thyroid cancers by blocking cancer cell growth and spread.
| Composition | Cabozantinib |
| Manufacturer | Aprazer |
| Packing | 30 Tablets |
| Prescribed For | Kidney, Liver, and Thyroid Cancers |
| Expiry | December 2027 |
Lenced 10mg Capsule contains Lenvatinib, a targeted cancer therapy used to treat thyroid cancer, liver cancer (HCC), and kidney cancer (RCC).
| Composition | Lenvatinib |
| Manufacturer | Zydus Cadila |
| Packing | 30 Capsules |
| Prescribed For | Thyroid cancer, Liver cancer, and Kidney cancer |
| Expiry | December 2027 |
Lenshil contains Lenvatinib 4mg, a targeted cancer medicine used in the treatment of thyroid cancer, kidney cancer (renal cell carcinoma), and liver cancer (hepatocellular carcinoma).
| Composition | Lenvatinib |
| Manufacturer | Shilpa Medicare Ltd |
| Packing | 10 Capsules |
| Prescribed For | Thyroid Cancer, Kidney Cancer, Liver Cancer |
| Expiry | December 2027 |
Lentris contains Lenvatinib 10mg, a targeted cancer therapy used to treat advanced stages of thyroid cancer, liver cancer (hepatocellular carcinoma), and kidney cancer (renal cell carcinoma).
| Composition | Lenvatinib |
| Manufacturer | Mylan Pharmaceuticals Pvt Ltd |
| Packing | 30 Capsules |
| Prescribed For | Thyroid Cancer, Kidney Cancer, Liver Cancer |
| Expiry | December 2027 |
Lenvakast contains Lenvatinib 10mg, a targeted therapy used in the treatment of advanced thyroid cancer, renal cell carcinoma (kidney cancer), and hepatocellular carcinoma (liver cancer).
| Composition | Lenvatinib |
| Manufacturer | Aprazer Healthcare Pvt Ltd |
| Packing | 30 Capsules |
| Prescribed For | Thyroid Cancer, Kidney Cancer, Liver Cancer |
| Expiry | December 2027 |
Lenvat contains Lenvatinib 10mg, a targeted therapy used in the treatment of thyroid cancer, kidney cancer (renal cell carcinoma), and liver cancer (hepatocellular carcinoma).
| Composition | Lenvatinib |
| Manufacturer | Natco Pharma Ltd |
| Packing | 30 Capsules |
| Prescribed For | Thyroid Cancer, Kidney Cancer, Liver Cancer |
| Expiry | December 2027 |
Lenvatol contains Lenvatinib 10mg, a targeted anti-cancer medicine used for treating certain types of advanced or metastatic cancers including thyroid cancer, renal cell carcinoma (kidney cancer), and hepatocellular carcinoma (liver cancer).
| Composition | Lenvatinib |
| Manufacturer | Cipla Ltd |
| Packing | 10 Capsules |
| Prescribed For | Thyroid Cancer, Kidney Cancer, Liver Cancer |
| Expiry | December 2027 |
Lenvenib contains Lenvatinib 4mg, a targeted cancer therapy used to treat advanced thyroid cancer, kidney cancer (renal cell carcinoma), and liver cancer (hepatocellular carcinoma).
| Composition | Lenvatinib |
| Manufacturer | Sun Pharmaceutical Industries Ltd |
| Packing | 7 Capsules in 1 Strip |
| Prescribed For | Thyroid Cancer, Kidney Cancer, Liver Cancer |
| Expiry | December 2027 |
Glenvas 10mg Capsule contains Lenvatinib, an oral targeted therapy used to treat certain types of advanced cancers, including thyroid cancer, liver cancer, kidney cancer, and endometrial cancer.
| Composition | Lenvatinib |
| Manufacturer | Glenmark Pharmaceuticals Ltd |
| Packing | 30 Capsules |
| Prescribed For | Thyroid, Liver & Kidney Cancer |
| Expiry | December 2027 |
Bdfoie 10 mg Capsule contains Lenvatinib, a targeted therapy used in the treatment of certain types of cancers including thyroid cancer, advanced renal cell carcinoma (kidney cancer), and hepatocellular carcinoma (liver cancer).
| Composition | Lenvatinib |
| Manufacturer | BDR Pharmaceuticals |
| Packing | 30 Capsules |
| Prescribed For | Thyroid, Kidney, Lung Cancer |
| Expiry | December 2027 |
